PCV81 - COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN FOR HIGH-RISK PATIENTS WITH ESTABLISHED PERIPHERAL ARTERIAL DISEASE IN CHINA
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.627
https://www.valueinhealthjournal.com/article/S1098-3015(18)33927-5/fulltext
Title :
PCV81 - COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN FOR HIGH-RISK PATIENTS WITH ESTABLISHED PERIPHERAL ARTERIAL DISEASE IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33927-5&doi=10.1016/j.jval.2018.09.627
First page :
Section Title :
Open access? :
No
Section Order :
44